Background: National Tuberculosis and Leprosy Control Program (NTBLCP) adopted Stop TB strategy in 2006 as a result of high TB burden which outlined engagement of all care providers including Private Pharmacists (PP) in TB control. However, there were no previous baseline studies done on knowledge and practices on TB control among private pharmacists needed to appraise their potential role and contribution to TB control which forms the basis of this study.
Introduction
Tuberculosis is a major cause of illness and death worldwide, and Nigeria is one of the most affected countries. The World Health Organization (WHO) classifies Nigeria as one of 22 "high-burden countries" -nations that together account for 80 percent of TB cases worldwide. The country's 2009 incidence rate for all forms of TB was 295/100,000 people, with prevalence rate of 497/100,000. Furthermore, prevalence of MDR TB among new TB cases is 1.8% and 7.7% among previously treated TB. [1] The disease has been the target of a national control program since 1990, and the DOTS strategy was adopted in 1994. TB care and treatment are free in Nigeria. Patients with symptoms suggestive of TB identified when they visit a first-level health service are supposed to be referred to a directly observed treatment short course center, where a diagnosis of TB can be confirmed. The main diagnostic tools used are the sputum smear test and or chest radiography for those who are smear negative. When the diagnosis is confirmed, standard treatment regimens are prescribed in accordance with World Health Organization (WHO) recommendations.
Efforts to stop the spread of the disease are consistently hindered by a case detection rate that hovers around 40 percent, which means that people with active TB are not being found by the national health system and referred to DOTS (directly observed therapy, short-course) centers for treatment. In addition, collaboration between this provider and National tuberculosis program in Bolivia has led to increase in the number of clients referred for Tuberculosis diagnosis and treatment in the public settings. [5] In Nigeria, private pharmacists constitute first point of contact to people seeking health care and therefore can play a critically important role in the national public health system. A lot of patients with symptoms of tuberculosis including the very poor seek for care from variety of care providers outside NTBLCP including private pharmacists and are derived of benefits of directly observed treatment short course therapy. Little is known about their contribution to tuberculosis care particularly in Nigeria. This study seeks to provide relevant information about tuberculosis case detection skills among private pharmacists in Osogbo, South Western Nigeria for the purpose of policy initiation, planning and decision making. Sampling Method: Register of association of private pharmacists was used as sampling frame. Systematic random sampling was applied to select respondents from the sampling frame using a sampling interval. The selection was done on one of those days of their monthly meetings.
Materials and Methods

Research Instrument for Data Collection:
Research instrument was semi structured selfadministered pre tested questionnaires. Study variables include socio-demographic characteristics of respondents, knowledge and practices regarding control of TB according to National tuberculosis guidelines. When asked on awareness of Tuberculosis diagnosis according to National guidelines, 38 (80.9%) are aware, 19 (50%) mentioned sputum smear microscopy while 23.7% identified sputum microscopy with chest x-ray. Only 5 (10.6%) knew that the total duration of treatment was for 8 months out of which 3 (6.3%) could list all four category of drugs recommended for standard treatment of tuberculosis among adults while as low as 4.3% knew correct mode of monitoring patients on treatment using weight, sputum microscopy and drug intake. (Table 3 )
Discussion
The private health sector is a valuable resource, located close to, and trusted by, many TB patients and suspects. By involving Private pharmacists, NTBLCPs can increase case detection. Since many patients first approach PPs, there is an opportunity to reduce diagnostic delay with a concurent reduction in transmission. By enlisting PPs, NTPs can enhance patient access and acceptance, thereby improving treatment outcomes. There is also the potential to share service delivery with the private pharmacists and thus moderate the workload on frontline health workers.
Knowledge about symptoms of tuberculosis was quite good among the private pharmacists interviewed in this study as more than half mentioned prolonged cough of 2-3 weeks duration, weight loss and night sweats. This result was similar to findings on tuberculosis case detection skills among private pharmacies in Ho However, when asked to make a recommendation for a person with suspected pulmonary Tuberculosis, just above one quarter of respondents mentioned sputum smear as the best diagnostic test for pulmonary TB, twenty two per cent mentioned X-ray only, twenty one percent mentioned both sputum smear and Chest X-ray. These findings confirmed delay in TB diagnosis and commencement of treatment by majority thereby leading to an increase in disease transmission thus presenting a strong case for addressing private pharmacists' involvement in TB care. In addition, majority of the participants did not know 8 months standard duration of treatment, the names of drugs used for category one clients, correct mode of monitoring patients on treatment, such management practices if unchecked could contribute to the evolution and spread of MDR TB as well as diluting epidemiological impact of the DOTS programmes. To top it all, this shows clearly a major communication void between TB programmes and Private Pharmacists.
This sector poses both threats and opportunities to effective TB control. There is yet an unutilised potential for the NTBLCP to bring the pharmacies into the passive case detection strategy. Tuberculosis case detection rate could be increased and diagnostic delay decreased if information on standard guidelines on diagnosing and treating tuberculosis from NTBLCP targeted private pharmacies.
Education and information can be used to improve tuberculosis case management practices among private pharmacists. Continuous medical education (CME) sessions and dissemination of NTBLCP guidelines in user-friendly formats could conceivably boost the specificity and sensitivity of the overall diagnostic process. It could reduce the portion of diagnostic delay attributable to provider misjudgement as well as reduce nonspecific treatment and avert unnecessary laboratory examinations. Further, it could induce wider use of recommended prescriptions and could promote record keeping.
Conclusion
Private pharmacies are often the first port of call for patients seeking healthcare. They need to be aware of the common symptoms of tuberculosis and be able to refer patients to appropriate facilities for diagnosis and management. Furthermore, private pharmacies need to be aware of the current treatment regimens and be in a position to advise the patients accordingly.
